| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.26B | +1.4% |
| Cost of Revenue | $2.52B | +9.6% |
| R&D Expense | $528.0M | +12.1% |
| SG&A Expense | $1.89B | +11.1% |
| Interest Expense | $527.0M | +24.9% |
| Pre-tax Income | $673.0M | -40.0% |
| Income Tax | -$350.0M | -270.7% |
| Net Income | $1.02B | +11.6% |
| EPS (Basic) | $4.01 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $693.0M | -1.8% |
| Accounts Receivable | $1.74B | +18.2% |
| Inventory | $1.31B | +31.1% |
| Current Assets | $4.51B | +14.7% |
| Total Assets | $12.06B | +10.1% |
| Current Liabilities | $2.92B | +16.2% |
| Long-term Debt | $8.76B | -1.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $251.0M | +28.1% |
| +11.1% |
| EPS (Diluted) | $3.99 | +11.1% |
| Total Liabilities |
| $12.13B |
| +2.4% |
| Stockholders' Equity | -$70.0M | +92.2% |